Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.

ABSTRACT:

Introduction

Systemic treatment with chemotherapy is warranted for patients with extensive-stage SCLC (ES-SCLC). The objective of this study was to determine whether racial and other healthcare disparities exist in receipt of chemotherapy for ES-SCLC.

Methods

Utilizing the National Cancer Database, 148,961 patients diagnosed to have stage IV SCLC from 2004 to 2016 were identified. Adjusted ORs with 95% confidence intervals (95% CIs) were computed for receipt of chemotherapy using multivariate logistic regression modeling. Cox regression modeling was used to perform overall survival analysis, and adjusted hazard ratios were calculated.

Results

A total of 82,592 patients were included, among which chemotherapy was not administered to 6557 (7.9%). Higher education, recen

SUBMITTER: Tapan U 

PROVIDER: S-EPMC8474393 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature